Such explanation is in line with the hypothesis that KRAS mutation as the one of the “driver mutations” occurs early in the NSCLC development (Alsdorf et al. 2013; Li et al. 1994). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.